| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CNS Pharmaceuticals, Inc. | Director | Restricted Stock Units | 53.1K | $15.9K | $0.30 | Apr 8, 2024 | Direct |
| Annexon, Inc. | Director | Stock Option (Right to Buy) | 44K | Jun 5, 2024 | Direct | ||
| CNS Pharmaceuticals, Inc. | Director | Option to purchase common stock | 35.6K | Apr 8, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ANNX | Annexon, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| CNSP | CNS Pharmaceuticals, Inc. | Apr 8, 2024 | 2 | $0 | 4 | Apr 10, 2024 | Director |
| CNSP | CNS Pharmaceuticals, Inc. | Sep 21, 2023 | 1 | $0 | 4 | Sep 25, 2023 | Director |
| CNSP | CNS Pharmaceuticals, Inc. | Sep 14, 2023 | 2 | $0 | 4/A | Oct 12, 2023 | Director |
| ANNX | Annexon, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| CNSP | CNS Pharmaceuticals, Inc. | May 5, 2023 | 1 | $0 | 4/A | Aug 10, 2023 | Director |
| CNSP | CNS Pharmaceuticals, Inc. | May 3, 2023 | 0 | $0 | 3 | May 9, 2023 | Director |
| ANNX | Annexon, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| ANNX | Annexon, Inc. | Jan 19, 2022 | 1 | $0 | 4 | Jan 20, 2022 | Director |
| ANNX | Annexon, Inc. | Jan 19, 2022 | 0 | $0 | 3 | Jan 20, 2022 | Director |